IFIH1 and clinically amyopathic dermatomyositis: It was found that positive anti-MDA5 antibodies were associated with a high prevalence in patients with DM, especially in CADM patients with no or mild muscle symptoms, and Chen et al. found that nearly half of adult CADM patients had anti-MDA5 antibodies.